Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Pascarella

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
JAMA Network Open|March 10, 2025
Second-Line Medications for Women Aged 10 to 50 Years With Idiopathic Generalized EpilepsyEmanuele Cerulli Irelli, Enrico Cocchi, Joanna Gesche, et al.
Neurology and Therapy|November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Epilepsy & Behavior : E&B|November 27, 2025
Epilepsy beyond seizures: embracing a holistic perspective. Proceedings of the 2nd meeting (Episicily) of the epilepsy study group of the Italian Society of neurologyAngelo Labate, Eleonora Palma, Vincenzo Belcastro, et al.
European Journal of Neurology|December 10, 2020
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of "organic" neurologyMichele Tinazzi, Christian Geroin, Roberto Erro, et al.
Epilepsia|December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE studyRoberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
JAMA Neurology|February 9, 2026
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal EpilepsyEmanuele Cerulli Irelli, Roberta Roberti, Maria Sole Borioni, et al.
Journal of Neurology|March 22, 2026
Clinical features of adolescent-onset functional motor disorders in tertiary movement disorders centersChristian Geroin, Tommaso Ercoli, Enrico Marcuzzo, et al.
Epilepsia|March 15, 2025
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS studySimona Lattanzi, Fedele Dono, Giuseppe d'Orsi, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
JAMA Network Open|March 10, 2025
Second-Line Medications for Women Aged 10 to 50 Years With Idiopathic Generalized EpilepsyEmanuele Cerulli Irelli, Enrico Cocchi, Joanna Gesche, et al.
Neurology and Therapy|November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Epilepsy & Behavior : E&B|November 27, 2025
Epilepsy beyond seizures: embracing a holistic perspective. Proceedings of the 2nd meeting (Episicily) of the epilepsy study group of the Italian Society of neurologyAngelo Labate, Eleonora Palma, Vincenzo Belcastro, et al.
European Journal of Neurology|December 10, 2020
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of "organic" neurologyMichele Tinazzi, Christian Geroin, Roberto Erro, et al.
Epilepsia|December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE studyRoberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
JAMA Neurology|February 9, 2026
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal EpilepsyEmanuele Cerulli Irelli, Roberta Roberti, Maria Sole Borioni, et al.
Journal of Neurology|March 22, 2026
Clinical features of adolescent-onset functional motor disorders in tertiary movement disorders centersChristian Geroin, Tommaso Ercoli, Enrico Marcuzzo, et al.
Epilepsia|March 15, 2025
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS studySimona Lattanzi, Fedele Dono, Giuseppe d'Orsi, et al.
Pageof 7